CLPT
Clearpoint Neuro Inc
NASDAQ: CLPT · HEALTHCARE · MEDICAL DEVICES
$11.18
+8.12% today
Updated 2026-04-30
Market cap
$353.24M
P/E ratio
—
P/S ratio
9.55x
EPS (TTM)
$-0.90
Dividend yield
—
52W range
$8 – $30
Volume
0.8M
Clearpoint Neuro Inc (CLPT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-69.10%
Operating margin
-50.40%
ROE
-95.60%
ROA
-20.40%
Debt/equity
2.25x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | $2.67M | $-9.45M | 99.39% | -356.45% | -354.16% |
| 2011 | $3.82M | $-8.31M | 82.81% | -155.09% | -217.68% |
| 2012 | $5.06M | $-5.71M | 89.01% | -61.87% | -112.83% |
| 2013 | $3.93M | $-7.09M | 63.84% | -190.17% | -180.29% |
| 2014 | $3.60M | $-4.52M | 46.53% | -147.61% | -125.53% |
| 2015 | $4.59M | $-8.45M | 56.74% | -195.34% | -183.91% |
| 2016 | $5.75M | $-8.07M | 54.03% | -130.25% | -140.36% |
| 2017 | $7.38M | $-7.17M | 60.72% | -85.86% | -97.12% |
| 2018 | $7.35M | $-6.16M | 66.91% | -71.37% | -83.82% |
| 2019 | $11.22M | $-5.54M | 64.86% | -40.96% | -49.39% |
| 2020 | $12.83M | $-6.78M | 71.09% | -48.48% | -52.86% |
| 2021 | $16.30M | $-14.41M | 68.24% | -82.05% | -88.41% |
| 2022 | $20.55M | $-16.43M | 65.84% | -79.47% | -79.97% |
| 2023 | $23.95M | $-22.09M | 56.83% | -93.70% | -92.21% |
| 2024 | $31.39M | $-18.91M | 60.92% | -62.91% | -60.25% |
| 2025 | $36.97M | $-25.54M | 61.38% | -65.36% | -69.08% |